In the relma-cel study, data were provided on the effect of the gene expression of tumor-associated fibroblasts (AP, TNC, CSPG4, PDGFRA, S100A4, ASPN, STC1, and ITGAM) and cytokines (CCL2, CCL3, CCL4, CCL5, CXCL8, CXCL9, CXCL10, CXCL11, CXCL12, CXCL16, IL-10, and TGF-β) and their receptors (CCR6, CCR10, CXCR3, and CXCR4) on the probability of achieving CR [59]. The gene discussed is ITGAM; the disease is neoplasm.